Adalimumab in severe and acute sciatica: A multicenter, randomized, double‐blind, placebo‐controlled trialStéphane Genevay, Cem Gabay, Sébastien Viatte et al.|Arthritis & Rheumatism|2010Cited by 63
Reliability and validity of the cross-culturally adapted French version of the Core Outcome Measures Index (COMI) in patients with low back painStéphane Genevay, Anne F. Mannion, Christine Cedraschi et al.|European Spine Journal|2011Cited by 57
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trialStéphane Genevay, Cem Gabay, Axel Finckh et al.|Annals of the Rheumatic Diseases|2011Cited by 51
488 ADALIMUMAB IN SEVERE AND ACUTE SCIATICA. A MULTICENTRE, RANDOMISED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIALStéphane Genevay, Cem Gabay, Sébastien Viatte et al.|European Journal of Pain Supplements|2010Cited by 5
[Conservative treatment of chronic low back pain: what is new in 2008?].Federico Balagué, Stéphane Genevay, G Ochoa Amaya|PubMed|2009Cited by 3